RIPK3 and breast cancer: TNFα/type I IFN enhancement of apoptotic priming in breast cancer recipient cells highlights a synergistic pro-death activity between these two inflammatory cytokines, recently reported to induce necroptosis in RIPK3 competent (non cancer) cells35.